Searched for
NOVARTIS PHARMA AG
Novartis case: Delhi HC pulls up patent office over decade-long delay in breast cancer drug approvalThe Delhi High Court has stepped in with a firm hand, criticizing the patent office for its sluggish response to Novartis AG's 2011 patent ...- Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 croreSwiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit for Rs 1,446 crore to a consortium led by ChrysCapital. This div...
- Market volatility derails Novartis' plan to sell stake in its India armNovartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strate...
- PE firms queue up for Novartis' Indian armThe PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and is also expec...
- Novartis puts its India-listed entity for up for saleThe strategic review will include an assessment of the 70.68% shareholding of Novartis AG in Novartis India. Novartis said there is no assu...
- JB Pharma inks Rs 1,089 cr pacts with Novartis for select ophthalmology brandsThe board of directors at its meeting held on December 19, 2023 approved the execution of a trade mark licence agreement with Novartis Inno...
- Delhi HC restrains generic pharma firms from making, selling patent drug of NovartisThe plea said the plaintiff through a press release of January 28, 2019 issued by the defendant came to know about its act in launching a p...
- Novartis divests anti-infectives brands to Samara CapitalThe portfolio of brands acquired focus on anti-infectives largely catering to the women's health and gynaecology segment, the spokesperson ...
- Samara Capital likely to buy Novartis brands"Samara Capital is bullish on this segment and 7-8 brands which are part of the anti-infective portfolio will be acquired as part of the de...
- Torrent completes acquisition of Novartis brandsLast month, Torrent had announced inking of pacts with Novartis AG to acquire the two brands.Torrent Pharma shares today ended 0.27 per cen...
- Ready to pay "reasonable" royalty to Novartis AG: Cipla to HCCipla was making submission for lifting the stay ordered by a single judge bench restraining it from manufacturing the drug.
- Delhi High Court notice to Novartis on Cipla plea"We will not give you an interim order. We will hear it on an early date and dispose it of. Notice. Renotify on February 5," the bench said.
- Novartis India Q3 net up 74.94 pc to Rs 40.50 crDrug firm Novartis India today said its net profit rose by 74.94 per cent to Rs 40.50 crore for the third quarter ended December 31, 2010, ...
- Novartis bids $ 470 mn for US cancer diagnostic firmIt says the price represents a 39 per cent premium over Genoptix's share value on Dec. 13, 2010, when rumors of a sale sparked a price surg...
- Aventis to exit JV with Novartis, sell stake for about Rs 100crAventis has agreed to continue to provide certain utilities in services to the Ankleshwar plant of CBVPL for a period of 3 yrs from the dat...
- Complete formalities on Novartis patent claim: SCThe Supreme Court on Friday directed the Centre, Cipla, Ranbaxy, Hetero Drugs, Natco Pharma and others to complete their pleadings in the m...
- FIs respond to Novartis’ open offerInstitutional shareholders have participated in a big way in Novartis AG’s open offer for its Indian subsidiary Novartis India, boosting th...
- Novartis hikes offer price for arm to Rs 450Novartis AG, the Swiss pharma giant, has increased the open offer price for its subsidiary Novartis India to Rs 450 from Rs 351 per share.
- Novartis' open offer hangs in balanceThe fate of the open offer of Swiss pharma giant Novartis to scale up its stake in its Indian subsidiary Novartis India looks uncertain wit...
- Novartis appeal excludes technical memberThe Union Government today informed the Madras High Court that the Intellectual Property Appellate Board (IPAB) could exclude technical mem...
Load More
